National Institute on Drug Abuse

The National Institute on Drug Abuse is a federal research institution whose work helps frame addiction in the book as both a biological process and a public-health crisis. Its significance lies not in a single intervention, but in the range of evidence associated with it: research into methamphetamine treatment and brain effects, national data on drug problems and treatment admissions, expert accounts of compulsion, and information directed at teenagers. The book draws on these resources to test explanations of addiction while showing how scientific knowledge can inform, but cannot settle, a family’s questions about responsibility, care, and recovery.

Research and public-health role

The account places the National Institute on Drug Abuse within a changing national response to methamphetamine. The drug’s use had risen and fallen over time, but experts described a newer epidemic spreading beyond western cities into the Midwest, the South, and the East Coast. Former Drug Enforcement Administration chief Asa Hutchinson called methamphetamine the country’s leading drug problem, while its effects pressed on law enforcement, policymakers, and health-care systems. These claims situate the Institute’s research in a problem that was at once local and national, and whose scale was not immediately reflected in official attention.

The book contrasts public acknowledgment with indicators of growing need. In 2006, a survey of five hundred local law-enforcement officials identified methamphetamine as their leading drug problem, well ahead of cocaine and marijuana. Later that year, a larger random sample of 3,400 drug-enforcement agencies found that 40 percent regarded methamphetamine as their most significant drug problem. These surveys are not interchangeable with clinical research, but together they show how the book assembles evidence from enforcement and health-care settings to describe the epidemic’s breadth.

Treatment admissions provide another measure. According to James Colliver of the National Institute on Drug Abuse, annual rehabilitation admissions for methamphetamine addiction rose from 28,000 in 1993 to about 150,000 in 2005, an increase of more than fivefold. A 2006 report by the Substance Abuse and Mental Health Services Administration also described treatment admissions for methamphetamine abuse as surging. The figures record people entering care rather than the full number of users, a distinction that matters to the account’s broader argument: the visible demand on treatment services was mounting, while no one statistic could fully measure the epidemic.

Research into treatment and the brain

The National Institute on Drug Abuse appears in the book’s discussion of federal research investment. As the methamphetamine epidemic began spreading, the Clinton administration earmarked millions of dollars for research into treatments. One aim was to determine whether damage to users’ brains was irreversible. If it was, the book explains, treatment might be limited to addressing symptoms or slowing deterioration rather than achieving full recovery. This was posed as a research question, not a settled conclusion, and it sharpened the author’s concern about what continued drug use might do to Nic.

The surrounding research narrative describes a proposed cycle linking brain chemistry, distress, and renewed use. Researchers told the author that methamphetamine binges can deplete as much as 90 percent of the brain’s dopamine. The resulting deficiency can intensify depression and anxiety; taking more of the drug may then contribute to further nerve damage and stronger compulsion to use. The book reports that some researchers therefore feared that methamphetamine’s neurotoxicity could make complete recovery difficult or impossible. By presenting this as a concern held by researchers, rather than as an established outcome for every user, the narrative conveys both the seriousness of the evidence and its limits.

The Institute’s experts also help the author consider addiction as compulsion. Its director, Nora Volkow, described a pattern across the addictions she had studied: she had not encountered an addicted person who wanted to be addicted, and she argued that something in the brain had led to the process. The account uses this view to challenge an easy equation between repeated drug use and a freely chosen desire for addiction. It does not erase the consequences of behavior; instead, it makes the question of choice more difficult by setting observable actions beside the possibility of a disorder that changes the conditions under which choices are made.

Disease, responsibility, and care

The disease model carries practical consequences in the book. The author notes that insurers cover diseases and pay for treatment, making the classification consequential beyond scientific debate. Delayed care can bring costs associated with organ replacement, mental illness, damaged families, lost work, and drug-related crime. At the same time, the account acknowledges disagreement: some critics argue that a biological explanation risks treating addiction as wholly involuntary. The Institute’s research and the arguments surrounding it therefore enter a continuing dispute over how to understand addiction, not a final verdict that removes personal or social responsibility.

That dispute becomes intimate when the author considers his son’s methamphetamine use. After Nic had used the drug, the author pleaded with him to enter rehabilitation but learned that, because Nic was over eighteen, a parent could not simply commit him. A brief psychiatric evaluation could be sought through a complicated process if he posed a danger to himself or another person; concern about drug use alone was not sufficient. The author later wished he had compelled treatment while Nic was still young enough for him to make that decision, while admitting that no one could know whether Nic would have been ready to hear its message. The scientific and legal discussions thus meet in a practical limit: knowledge of the risks did not give the family the power to choose treatment for an adult.

The author’s eventual recommendations remain cautious. He favors intervention earlier rather than later and considers a period of treatment potentially valuable even when a young person is not yet ready to understand recovery. He also argues that rehabilitation can interrupt cycles of use, although it cannot guarantee that relapse will not occur. His account does not present research as a substitute for continuing care or as proof of a certain outcome; it treats treatment as a means of creating time away from drugs and a chance to recover.

Education and the book’s use of evidence

The National Institute on Drug Abuse also appears as a source of public information. In the book’s reference material, the Institute is listed alongside methamphetamine information and a resource for teenagers. This educational role complements the account’s insistence that parents talk with children early and honestly about drugs, while taking account of a child’s age and understanding. The author cannot offer a single formula for what every family should disclose, but he rejects lying to his own children and expects Jasper and Daisy eventually to read the account.

The Institute’s presence also reflects the book’s movement between scales. The author draws together national trends, treatment statistics, researchers’ interpretations, and the particulars of a family living with addiction. In the acknowledgments, he thanks Richard Rawson, Edythe London, and other specialists for helping him understand addiction, while identifying the Institute’s director and a policy official among those who reviewed material. These connections establish a research-informed basis for the narrative without making the memoir itself a scientific report.

That distinction is central to the Institute’s narrative significance. Its research gives the author ways to describe compulsion, relapse risk, and the possible effects of methamphetamine on the brain; public data make clear that Nic’s experience belongs to a much wider crisis. Yet the evidence does not answer the book’s most painful uncertainties: whether an earlier intervention would have changed Nic’s course, how much recovery is possible, or when a parent should stop trying to direct an adult child. The National Institute on Drug Abuse supplies tools for asking those questions more carefully, not a promise that they can be conclusively answered.